Passage BIO PASG
NASDAQ PASG
$4.44 -0.04 (-0.89%)
At close: Aug 21, 2026 · 4:00 PM EDT

Passage BIO (PASG) EPS (Basic) (2019 - 2026)

Passage BIO (PASG) posted quarterly EPS (Basic) of -$4.9 for Q1 2026, up 51.82% year-over-year from -$3.22 in Q1 2025, and up 42.76% quarter-over-quarter from -$8.55 in Q4 2025.

Passage BIO (PASG) EPS (Basic) (2019 - 2026) Analysis & Trends

Passage BIO's EPS (Basic) history runs 8 years deep, the most recent figure standing at -$4.9 for Q1 2026.

  • In Q1 2026, EPS (Basic) rose 51.82% year-over-year to -$4.9; the TTM figure through Mar 2026 stood at -$43.44 (up 62.85% YoY), while the FY2025 annual figure was -$85.74, up 10.76% from the prior year.
  • EPS (Basic) for Q1 2026 stood at -$4.9, up from -$8.55 in the prior quarter.
  • The five-year high for EPS (Basic) was -$4.9 in Q1 2026, with the low at -$80.04 in Q4 2023.
  • The 5-year median for EPS (Basic) is -$19.61 (2024), against an average of -$28.87.
  • The sharpest annual moves came in 2022 and 2025: EPS (Basic) sank 109.8% in 2022, then surged 88.97% in 2025.
  • Passage BIO's EPS (Basic) stood at -$76.28 in 2022, then declined by 4.93% to -$80.04 in 2023, then climbed by 3.14% to -$77.52 in 2024, then jumped by 88.97% to -$8.55 in 2025, then soared by 42.76% to -$4.9 in 2026.
  • Business Quant data shows PASG's EPS (Basic) at -$4.9 in Q1 2026, -$8.55 in Q4 2025, and -$14.75 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 12.62
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 7.59
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -1.96
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 2.12
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.23
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -0.72
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -0.06
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.18
10 Passage BIO 13.99 Mn 13.99 Mn - -2.58

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.58
Mar 31, 2026 -4.90
Dec 31, 2025 -8.55
Sep 30, 2025 -14.75
Jun 30, 2025 -15.63
Mar 31, 2025 -10.16
Dec 31, 2024 -77.52
Sep 30, 2024 -11.96
Jun 30, 2024 -19.61
Mar 31, 2024 -22.08
Dec 31, 2023 -80.04
Sep 30, 2023 -26.98
Jun 30, 2023 -16.39
Mar 31, 2023 -20.32
Dec 31, 2022 -76.28
Sep 30, 2022 -17.94
Jun 30, 2022 -32.97
Mar 31, 2022 -34.67
Dec 31, 2021 -70.09
Sep 30, 2021 -18.69